Intellectual disability (ID) found in Down syndrome (DS), which is characterized by an extra copy of 234 genes on Chr21 is poorly understood. We first used two DS mouse models that either display an extra copy of the Dyrk1A gene or of the mouse Chr16 syntenic region. Exome sequencing of transcripts deregulated in embryonic hippocampus uncovers enrichment in genes involved in chromatin and synapse respectively. Using large-scale yeast two-hybrid screen (154 distinct screens) of human brain library containing at least 10 7 independent fragments, we identified 3,636 novel protein-protein interactions with an enrichment of direct interactors of both Chromosome 21(Hsa21) baits and rebounds in ID-related genes. Using proximity ligation assays, we identified that Hsa21-encoded proteins are located at the dendritic spine postsynaptic density in a protein network located at the dendritic spine post synapse. Hsa21 DYRK1A and DSCAM that confers a ~ 20-fold increase in Autism Spectrum Disorders (ASDs) are part of this dendritic spine postsynaptic network. We found that a DSCAM intracellular domain binds either DYRK1A or DLGs that are multimeric scaffolds for the clustering of receptors, ion channels, and associated signaling proteins. The DYRK1A-DSCAM interaction is conserved from drosophila to humans. The identified postsynaptic.network is enriched in ARC-related synaptic plasticity, ASDs and Late-Onset Alzheimer Disease.
INTRODUCTION
Down syndrome (DS) is the most common form of intellectual disability (ID), with an incidence of one in 800 births. It is a human genetic disorder, caused by the presence of a third copy of 234 genes from Homo sapiens autosome 21 (Hsa21) (1, 2). DS is one of the most complex viable genetic perturbations. In spite of a broad spectrum of clinical symptoms, features common to all DS variants are the intellectual deficit that impairs learning and memory and an increased risk of developing a dementia resembling Alzheimer's disease (AD), even in patients as young as 40 years old (3) (4) (5) . To date, the precise contribution of each Hsa21 protein overexpression to the cognitive impairment found in DS remains undetermined.
Here, we used two DS mouse models. The first model is a Dyrk1A BAC 189N3 model carrying a triplication of the ~152 kb mouse Dyrk1a locus containing the whole mouse Dyrk1a gene with a 6 kb flanking fragment on the 5' side and a 19 kb flanking fragment on the 3' side (6) .
The second model is a transgenic line (Dp(16)1Yey) carrying a triplication of 22.9 Mb from Mus musculus chr16 (Mmu16), which are syntenic to 119 genes from Hsa21, including DYRK1A
(dual-specificity tyrosine phosphorylated and regulated kinase 1A) (7) , thus precisely reflecting the gene dosage of Hsa21 orthologs. The Dyrk1A gene was found to be a major player in DS whom overexpression induces modifications in synaptic plasticity both in the hippocampus and in the prefrontal cortex (8, 9) . Dyrk1a is an important candidate suggested to be involved in the learning and memory impairment seen in DS patients (10) , but the regulatory pathways impaired by trisomy of DYRK1A remain elusive.
In this work, we examined the respective contributions of Dyrk1a and other Hsa21 gene products in pathways linked to ID. Exome sequencing of transcripts mis-regulated in the embryonic hippocampus uncover two contrasting repertoires of genes: chromatin related genes for the Dyrk1A trisomy model and a synapse related genes for the Dp(16)1Yey model.
In order to gain further insight into the molecular network of proteins responsible for DS phenotypes, we next searched for human brain proteins that interact with proteins encoded by Hsa21. To this end, we conducted a large-scale yeast two-hybrid screen using Hsa21 baits and a human brain library of targets. This analysis revealed that both direct interactors of Hsa21-encoded proteins and their direct rebounds are enriched in proteins involved in ID.
Moreover, we found an enrichment in HSA21-encoded proteins that are part of a network located in dendritic spine postsynaptic density. The same interactome is also enriched with proteins involved in ARC-related synaptic plasticity, Autism Spectrum Disorders and Late-Onset Alzheimer Disease (LOAD). Supplementary Table S1 Supplementary Table S2 We used the 189N3 and the Dp(16)1Yey/+ DS mouse models. We performed RNA sequencing on embryonic E17 hippocampi of these two DS models. We identified 84 deregulated genes in 189N3 mice ( Supplementary Table S1 ) and 142 deregulated genes in Dp (16) 1Yey/+ ( Supplementary Table S2 ) compared to their littermate controls.
RESULTS

Whole
Gene ontology (GO) Process analyses of differentially expressed genes revealed a deregulation of chromatin proteins for 189N3 mice with: GO:0006334~nucleosome assembly (P value=1.17 e -08 ) GO:0031497~chromatin assembly (P value= 5.98 e -08 ) GO:0034728~ nucleosome organization (P value = 1.71 e -07 ).
Deregulation of chromatin proteins is in agreement with data that previously reported by us (11, 12) .
In contrast, for Dp (16) Interestingly, for the GO:0051932~synaptic transmission, GABAergic, 6 of 77 genes are deregulated for a repertoire of 53 out of 24850 human genes (7.8%), indicating an enrichment of 36.54 fold compared to expectations (hypergeometric P-value = 1.48 e-08 ). This result is in full agreement with the impairment of excitation-inhibition balance (E-I balance) in synaptic activity found in DS (13, 14) .
First, we used Dapple analysis (15) of 189N3 and Dp(16)1Yey/+ differential expressed genes to evidence two contrasted networks with statistically significance (direct edge counts; p<0.05)
showing that genetic variation induced by the triplication of the mmu16 affects a limited set of underlying mechanisms (Figure 1 A- 
Establishment of a Hsa21 protein-protein interaction map by a high-throughput, protein
domain-based yeast two-hybrid (Y2H) screening
Figure. 3.
Figure. 4
To improve our knowledge of the molecular network underlying DS, we performed a largescale protein-protein interaction study. We performed 72 screens with HSA21 protein as baits and 82 screens against their direct interactors (rebounds) using a highly complex randomprimed human adult brain cDNA library. We identified 1687 and 1949 novel direct interactions (Figure 3 A-D) . These interactions were ranked by category (a to f), using a Predicted Biological Score (PBS) (18) . Analysis of direct interactors from 72 HSA21 baits screens gives 1687 novel interactions identified with 76 already known (Biogrid) interactions confirmed ( Figure 3A-B ). Analysis of direct interactors from 82 rebound screens gives 1949 novel interactions were identified with 97 already known (Biogrid) interactions confirmed (Figure 3 C-D). We next compared these direct interactors with three lists of genes involved in intellectual disability (19, 20) . Both HSA21 direct interactors ( We realized a biological processes analysis using GO DAVID (see methods) (Figure 4) . The colored nodes correspond to the most significant results with GO:0022008~Neurogenesis (p-value=3.06e-17); GO:0048812~Neuron projection morphogenesis (p-value=, 2.91e-13);
GO:0050767~Regulation of neurogenesis (p-value=2.66e-06); GO:0043632~Modificationdependent macromolecule catabolic process (p-value=6.46e-05); GO:0051962~Positive regulation of nervous system development (p-value=6.29e-06); GO:0045665~Negative regulation of neuron differentiation (p-value=1.55e-07). Altogether, our data indicate an enrichment of interactions related to neuronal differentiation.
Linking HSA21 proteins to Late Onset Alzheimer Disease (LOAD) and neuropsychiatric diseases: DSCR9-CLU, DYRK1A-RNASEN
Figure 4 Supplementary Figure1
We first focused our analysis to two novel interactions with a potential importance in brain diseases, by combining Yeast two Hybrid (Y2H) interaction data with proximity ligation assays (PLA) that allow to localize PPI at the subcellular level when the maximal distance between the antibodies required for producing a signal is 40 nm (21).
The two selected PPI links respectively HSA21 DSCR9 gene with CLU, a risk factor for Late-Onset Alzheimer Disease (LOAD), HSA21 DYRK1A with RNASEN, a microprocessor complex subunit ( Figure 4A ).
As no bona fide antibody was available, we generated a GFP DSCR9 construct, in order to image DSCR9 protein. PLA evidenced nuclear localization of this novel interaction between DSCR9 and CLU. Using in situ PLA, we identified PPI inside nuclei on primary cortical neurons using anti-GFP and anti-Clu antibodies (Figure 4B ). DSCR9 and DSCR10 have been identified as genes that appeared exclusively in primates such as chimpanzee, gorilla, orangutan, crab-eating monkey and African green monkey and are not present in other nonprimate mammals (22) (Supplementary Figure 1) . CLU gene was identified as one of the 20 LOAD genetic risks (23) and confirmed in a recent meta-analysis a large genome-wide association meta-analysis of clinically diagnosed LOAD (94,437 individuals) (24) . Our results indicate a direct nuclear interaction between the product of a HSA21 gene that contributes to the genomic basis of primate phenotypic uniqueness and a LOAD risk gene.
For DYRK1A-DGRC8 interaction, we first validated this interaction by immunoprecipitation using native conditions (no overexpression) in EK293 cells ( Figure. 4C) . Localization of the interaction in neuronal nuclei was evidenced by PLA on primary cortical neurons transfected at DIC5 with Dyk1a-GFP construct, using anti-GFP and anti-Rnasen antibodies (Figure. 4D) .
The Microprocessor complex is a protein complex involved in the early stages of processing microRNA (miRNA) in animal cells. The complex is minimally composed of the ribonuclease enzyme Drosha and the RNA-binding protein DGCR8 (also known as Pasha) and cleaves primary miRNA substrates to pre-miRNA in the cell nucleus (25) .
Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion that gives a schizophrenia phenotype in humans, results in altered short-term plasticity in the prefrontal cortex (26) . One can suppose that functional phenocopies of this DGC8 haploinsufficiency may occur by titration of its partner RNASEN when DYRK1A is overexpressed. As alterations of the microRNA network cause neurodegenerative disease (27) , our results suggest that DYRK1A-RNASEN interaction could have direct relevance for our understanding of early AD in DS persons. We next wanted to validate PPI identified by Y2H and to define the subcellular localization of the interactions, using proximity ligation assays. Our working hypothesis was that a subset of Hsa21 proteins and their interactors could be located at the level of dendritic spine. We defined a putative synaptic network ( Figure 5A ) based on the Y2H that we identified and their position in a four layers model as proposed by (28, 29) . The four layers involve (i) a membrane layer for ionic channels, neurotransmitter receptors and cell-adhesion molecules, (ii) a second layer for DLGs, (iii) a third layer for DLGAPs and (iv) a fourth layer for direct DLGPs interactors (such as SHANKs). Validation of the synaptic network was done using PLA.
Interactome of
We were able to quantify dendritic spine postsynapse localization for 21 PPI identified by Y2H, We first focused on protein-protein interactions of Hsa21 GRIK1 (Figure 5B) . This protein is one of the GRIK subunits functioning as a ligand-gated ion channel. Kainate receptors (KARs) are found ubiquitously in the central nervous system (CNS) and are present pre-and postsynaptically (30) . We first identified the GRIK1-KCNQ2 interaction. As KCNQ2 potassium channels are known to functionally interact with HCN1 potassium channels in prefrontal cortical dendritic spines (31), we validated that HCN1, KCNQ2 and GRIK1 physically interact in dendritic shafts and spines using PLA and found a direct interaction between GRIK1 and HCN1 in these compartments. We also identified and validated interactions between GRIK1 with SEPT7 and KALRN. SEPT7, a member of the septin family of GTPases, is localized to dendritic branching points and spine necks (32) . KALRN is a Rho-GEF exclusively localized to the postsynaptic side of excitatory synapses (33) and binds NMDA receptor subunit Nr2b (Grin2b) (34) . These results suggest that GRIK1 is part of two synaptic complexes, one located near PSD-95 (DLG4) at the tip of the dendritic spine and the other at the neck of spines.
Hsa21 HUNK (alias MAK-V) was found in the Y2H screen to interact with the GTPaseactivating protein AGAP3, the actin-associated protein Synaptopodin (SYNPO) and the synapse related LIMK1. These three interactions were validated at the level of synapse using PLA ( Figure 5C ). AGAP3 was recently identified as an essential signaling component of the NMDA receptor complex that links NMDA receptor activation to AMPA receptor trafficking (35) .
SYNPO was localized to necks of dendritic spines and linked to the spine apparatus, assumingly playing an essential role in regulating synaptic plasticity (36) . These results suggest that HUNK is involved in complexes localized both near PSD-95 and the spine apparatus. LIMK1 functions in intracellular signaling and is strongly expressed in the brain, with hemizygosity suggested to impair visuospatial constructive cognition (37) .
We next analyzed Hsa21 TIAM1 interaction with BIN1 and DLG1. TIAM1 is a Rac1 associated GEF 1, involved in synaptic plasticity (38) and specifically expressed in subgroups of glutamatergic synapses such as dendritic spines of the performant path-dentate gyrus hippocampal synapse (39) (Supplementary Figure 2) . BIN1 is the second risk factor, after APOE4, identified by Genome Wide Association Studies (GWAS) in LOAD (23, 24) . BIN1
protein has multiple functions, including a role at the postsynapse (40, 41) . Using PLA, we evidenced TIAM1-BIN1 and TIAM1-DLG1 interactions at the level of dendritic spines ( Figure   5C ).
Another set of noteworthy interactions identified in the Y2H screen ( Figure 5A) , as well as validated via PLA (Figure 5D ), is between Hsa21 potassium channel KCNJ6, a voltageinsensitive potassium channel member of the kainate ionotropic glutamate receptor (GRIK) family, and three DLG members: DLG1, DLG2 and DLG4. We also found an increase in the number of KCNJ6-DLG2 interactions in the Dp(16)1Yey transgenic mouse model, compared to the control. In contrast, the number of GRIN2A/B-DLG2 interactions was unchanged ( Figure   5D ). KCNJ6 is expressed in dendrites and dendritic spines at the PSD of excitatory synapses (42, 43) and its trisomy induces synaptic and behavioral changes (44) .
Two interesting interactions detected in the Y2H screen ( Figure 5A ) and validated via PLA ( Figure 5E ) are between Hsa21 Intersectin (ITSN1) and both SNAP25 and DLG-Associated Protein 1 (DLGAP1/GKAP). SNAP25, a member of the SNARE protein family, is not only essential for the exocytosis of synaptic vesicles (45) , but involved in trafficking of postsynaptic NMDA receptors (46) and spine morphogenesis (47) . DLGAP1 is a core protein of the scaffolding complex of the synapse (48) . These results are in agreement with the Itsn1 mutant mice phenotype that is characterized by severe deficits in spatial learning and contextual fear memory (49) and in synaptic hippocampal plasticity (50) . SIPA1L1, also known as SPAR is a Rap-specific GTPase-activating protein (RapGAP), a regulator of actin dynamics and dendritic spine morphology, leading to its degradation through the ubiquitin-proteasome system (51, 52) . Here, we evidenced direct interaction between SIPA1L1 and DYRK1A or DLG4 ( Figure 5F ) DYRK1A and DLG4
We also identified the location of the Y2H interactions of DSCAM with DLG2 (Discs large 2) and DLG4 at the dendritic spines, using PLA ( Figure 5G) . Then, using DSCAM as bait against single DLG family members (one-by-one Y2H approach), we identified interactions between DSCAM and the four members of the DLG family: DLG1, DLG2, DLG3, and DLG4 (Figure 5G-H ). DSCAM is known to regulate dendrite arborization and spine formation during cortical circuit development (53) . DLG1 (alias SAP97), DLG2 (alias PSD93/chapsyn-110) and DLG4
(alias PSD-95/SAP90) are known to bind various proteins and signaling molecules at the postsynaptic density (PSD) (54, 55) . Intriguingly, mice lacking Dlg2 and people with Dlg2 mutations display abnormal cognitive abilities (56) .
Altogether, our results demonstrate location of novel proteins in the nanoscale region that corresponds to the four layers of the dendritic spine and covers a 75 nm-thick region from synaptic cleft (57) .
DSCAM-DYRK1A interaction
Figure 6
In our Y2H screens, we identified interactions between human DSCAM, its human paralog DSCAML1 and human DYRK1A. This interaction occurs in the same intracellular domain (45 amino acids) of these cell adhesion molecules ( Figure 6A ). Furthermore, their drosophila homologs, DSCAM4 and minibrain (MNB), were also found to interact in the same phylogenetically conserved domain of 45 amino acids ( Figure 6B) . We confirmed human DSCAM-DYRK1A interaction by immunoprecipitation, using adult mouse cortex ( Figure 6C) .
We were unable to find an anti DYRK1A antibody that can be used for PLA proximity ligation assay. We used preparation of synaptosomes and immunoprecipation to evidence DSCAM-DYRK1A interaction in this subcellular fraction (Figure 6D-E) . We found that DSCAM interacts with DLG4 and DLG2 in the postsynapse, using PLA ( Figure 5G) . Altogether, our data indicate that DSCAM-DYRK1A and DLGs interacts in the postsynapse. To the best of our knowledge, this is the first localization of DSCAM and DYRK1A in the postsynapse.
Both DSCAM and DYRK1A are part of a subset of 30 genes that confers 20-fold risk in autismspectrum disorders (ASDs). In ASD, studies leveraging the statistical power afforded by rare de novo putatively damaging variants have identified more than 65 strongly associated genes (58) . The most deleterious variants (likely gene disrupting or LGD) in the highest confidence subset of these genes (N = 30) as a group confer approximately 20-fold increases in risk, with
LGD variants in the highest confidence genes carrying even greater risks (59) .
A synaptic network enriched in Hsa21 proteins, ASD high-risk genes, ARC-related protein network and Late Onset Alzheimer Diseases (LOAD) risk factors
Figure 7
We summarized our PPI data at the synapse with a protein network of 28 products (Figure 7) .
This synaptic network is enriched in HSA21 proteins with 5 out 234 HSA21 gene products (the results are enriched 18.72 fold compared to expectations; hypergeometric p-value = 6.435 e-07). This 28 proteins network is also enriched in high-risk ASDs genes. We found that DSCAM and DYRK1A are part of this network that includes also DLGAP1 and SHANK3. These four genes are considered to confer ~20-fold increases in risk, for a group containing 30 genes (58, 59 Altogether, these results demonstrate that our postsynaptic network is enriched in Hsa21 proteins, ASD high-risk genes, ARC-related protein network and LOAD risk factors.
Discussion
In spite of the availability of various mouse DS models, cognitive impairment phenotypes found in DS have not been related to specific alterations of molecular pathways. Furthermore, to the best of our knowledge, no specific pathways linked to synaptic alterations have been described in models overexpressing a given chr21 gene as compared to models overexpressing a syntenic region.
In the present study, we analyzed molecular changes in the hippocampus of two mouse DS models. We found molecular changes linked to chromatin remodeling in the Dyrk1A BAC Using large scale Y2H we evidenced that both direct interactors (n=1687) and their second order interactors that we capture using our rebound screen (n=1949) are enriched in ID genes.
This observation suggests that protein-protein complexes that includes a Hsa21 protein are atrisk complexes for ID.
The PLA approach that allows localizing Protein-Protein Interactions in a given subcellular comportment allows us to focus on synaptic compartment where subtle deregulations may occur (61, 62) .
We identified that interactions at the synapse are enriched in Hsa21 gene products. In particular, we were able to demonstrate that both DYRK1A and DSCAM are part of the postsynapse. DYRK1A and DSCAM are high-risk genes for ASDs with a 20 fold increase as compared to the general population (58, 59) . Gene dosage changes of both DYRK1A and DSCAM may involve distinct molecular mechanisms as compared to those occurring in ASDs and linked to damaging mutations. Further work to decipher these molecular changes can illuminate both DS and ASDs pathophysiology.
We also characterized a significant enrichment in ARC-dependent synaptic network involved in intelligence and brain diseases (17) . Mutations disrupting this molecular hierarchy can change the architecture of synaptome maps, potentially accounting for the behavioral phenotypes associated with neurological and psychiatric disorders (61) . Further work will be needed to analyze the changes in protein complexes at the synapse, when gene dosage changes for partners of these complexes.
It is well documented that Down syndrome, caused by trisomy of chromosome 21, is the single most common risk factor for early-onset Alzheimer's disease. Triplication of APP has been as considered as a candidate for this phenotype but trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP indicating that triplication of chromosome 21 genes other than APP is likely to have an important role to play in Alzheimer's disease pathogenesis in individuals who have Down syndrome (63) . We reported here an enrichment in LOAD genes identified by GWAS strategies, with RIN3, BIN1 and CASS4 in our postsynaptic network. We (40) and other (41) characterized BIN1 at the level of the synapse using super-resolution microscopy. Other protein networks that includes BIN1 and CASS4
have been reported in microglia (64) . Altogether, these results suggest that cell-distinct proteins complex may contribute to Alzheimer phenotype in DS.
Interestingly, from our Y2H and PLA approaches, we identified novel candidates in the postsynaptic domain that we characterized by four layers as in (28, 29) has a very restricted width in the range of 75 nm (57) . Super-resolution microscopy approaches recently revealed that spine synapses in vitro and brain slices nanodomains that form a trans-synaptic column and contain discrete, precisely aligned sub-diffraction nanomodules, whose number, not size, scales with spine volume (65, 66) .
Changes in stoichiometry of interactors, as expected for Hsa21 proteins may modify the functional impact of a given protein complex. The report that a same Neuroligin4 mutation can generate either ID or high-level ASD supports such subtle changes (67) . Similarly, some protein complexes may integrate only a given form of a protein, as it is the case for TIAM1 in glutamatergic synapses from entorhinal cortex (39) .
Together, our results suggest that protein-protein interactions identified here can be part of different dendritic spine signalosomes deregulated by three doses of Hsa21 proteins.
In conclusion, our results provide the first report, to our knowledge, of differential impacts of chromosome 21 DYRK1A on chromatin remodeling and of the 115 Hsa21 gene orthologs including DYRK1A, on synapse function. Our results exemplify the link of DS to other forms of ID and to degenerative diseases displaying complex genetics such as LOAD. The molecular pathways studied here can promote the development of novel therapeutic targets to treat cognitive impairments found in DS.
MATERIALS AND METHODS
Animals and genotyping
We used wild-type mice of the OF1 strain for neuronal primary culture, of the C57BL6 strain and 189N3 or Dp (16) 
Primary cell cultures and transfection
Cortical primary neurons were cultured as described above. At DIC5, the cells were transfected with constructs using Lipofectamine 2000 (Invitrogen), as described by the manufacturer. Cells were analyzed 48 hours after transfection at DIC7.
HEK293 cell cultures and transfection
HEK293 cell line were plated in 24-well plates in DMEM (Invitrogen) supplemented with 10% fetal bovine serum. At 70% confluency, the cells were transfected with constructs (cotransfections were performed at 1:3 ratio) using Lipofectamine 2000 (Invitrogen), as described by the manufacturer. Cells were analyzed 48 hours after transfection.
In situ proximity ligation assays (PLA) and microscopy
Cells were fixed by incubation for 20 min at room temperature in 4% paraformaldehyde in phosphate-buffered saline (PBS), permeabilized by incubation for 10 min at room temperature in 0.3% Triton X-100 in PBS, washed two times within PBS and PLA was realized according to the instructions of the manufacturer (DuoLink, Sigma). Primary antibodies used were as shown in Supplementary Table S3 . For the analysis of PLA interactions points, cells were scanned using the laser scanning confocal microscope (Leica, SP5 from PICPEN imagery platform Centre de Psychiatrie et Neuroscience) at 63× magnification, and Z-stacks were build using the ImageJ software (Wayne Rasband, NIH). Nuclear PLA interaction number was manually counted inside the nuclear body and normalized with the nuclear area of each neuron. Synaptic PLA interaction number was manually counted on 150 μm long dendritic segments starting after the first branch point in the dendritic tree. One 150 μm dendritic segment per neuron was analyzed.
Statistical analysis
The analyses performed on transgenic neurons with at least 3 embryos and at least 10 cells per embryo for synaptic and nuclear analyses. x SSC at 37°C. The regional distribution of radioactivity was analysed in the hippocampal region of wild-type and transgenic sections using a Micro Imager (Biospace Instruments) and
the Betavision analysis program (Biospace Instruments).
Protein extraction and Western blot analysis.
HEK293 cells or mouse cortex (pool from three adult OF1 mice) were homogenized on ice in Supplementary Table S3 . Membranes were washed in PBS 1x containing 0.05% tween 20 and incubated for 1 h at room temperature with anti-mouse, anti-rabbit or anti-goat HRP-conjugated secondary antibody. Membranes were washed three times in PBS 1x containing 0.05% tween 20. Immune complexes were visualized using the Clarity Western ECL Substrate (BioRad). Chemiluminescence was detected using the ChemiDoc XRS Imaging System (BioRad). Primary antibodies used were as shown in Supplementary Table S3 . As secondary antibodies, we used protein A or protein G IgG, HRPconjugated whole antibody (1/5,000; Abcam ab7460 or ab7456 respectively).
Immunoprecipitation
1mg of protein extracts were incubated, after preclear with 50µL of dynabeads (Novex), 3h at 4°C under rotating with 10 µg of primary antibody ( Supplementary Table S3 ; anti-mouse and anti-rabbit whole IgG (Millipore 12-371 and 12-370 respectively)). Add 50µL of protein A or protein G dynabeads and incubate 30mn at 4°C under rotating. Protein-antibody complexes were washed four times in 100 mM NaCl, 20 mM Tris-HCl, pH 7.4, 1% NP40 and analyzed by immunoblot.
Laser-assisted microdissection, Total RNA preparation and quantitative real-time PCR (Q-RT-PCR) analysis
Embryonic brain subregions were dissected as shown in Supplementary Figure. Reagents Stock solutions were prepared in water or DMSO, depending on the manufacturers' recommendation, and stored at -20°C. Upon experimentation, reagents were bath applied following dilution into ACSF (1/1000). D-APV and DCGIV were purchased from Tocris Bioscience. Salts for making cutting solution and ACSF were purchased from Sigma.
Bioinformatics evolutionary analysis
We performed 2 types of analysis. The first is based on extended haplotype homozygosity (EHH) 1 , the second is the composite multiple signal method (CMS) 2,3 .
Dataset
We used 1'000G data4. For the EHH approach we used SNVs and INDELs data of Europeans individuals. We didn't use ancestrale status of variants for this analysis because this information was not available for all variants.
For the CMS method, we used 1'000G dataset of European, Asian and African population. We inferred ancestral status of SNPs using the snp138OrthoPt4Pa2Rm3 table from UCSC website. We used the chimpanzee allele as ancestral if it was available, if not, we used the orangutan allele, and after the macaque allele. If these three alleles were unavailable we discarded the SNPs. We discarded all SNPs with derived allele frequency below 5% and with null minor allele frequency in European population of 1'000G.
Long Haplotypes Method
We used the R package rehh5 for this analysis. We calculated Integrated Haplotype Homozygosity (iHS) for all variants, standardized these scores within the chromosome according to frequency of minor allele and computed p-values (assuming iHS is normally distributed). We choose a cut-off of 3 and we obtained 211 variants from 120 016.
CMS method
We performed a scan of chromosome 21(hg19) with the CMS method 2,3 using the CMS genome wide score (CMSGW) as described earlier in Grossman et al. (2012) 3 .
Simulations We used the simulations described earlier in Grossman et al. (2010) 2 We performed 1'000 simulations for neutral selection and 15 scenarii with 300 replicas each for selective sweep in European population with the cosi program6. We used different values for the time of the end of the selective sweep (200, 400, 800 generations) and for the final frequency of the selected allele (0.2, 0.4, 0.6, 0.8, 1). Simulated regions were 1Mbp length and the selected alleles were in the middle of these regions as described previously.
CMS We used the CMSGW as described previously with minor changes:
 for the XPEHH-test. We used the XPEHH-test versus the 2 populations (AFR and ASN, 2 distributions) instead of taking the maximum value of the test according to 2 other populations.
 We used nucleotidic distance instead of genetic distance for the XPEHH-test and iHS test.
We computed CMSGW score of SNPs for which we had complete statistics (no infinite values, or missing data). This dataset represents 91639 SNPs on chr21. We used a cut-off on log10(score) of 2 corresponding approximatively of top 1% SNPs (see Supplementary Figure) .
We identified 100kb regions in which 30 % of SNPs were in our top 1% (see Figure) .
Venn Diagram Chr21 value indicates the number of coding genes carried by this chromosome.
Long haplotypes value indicates the number of coding genes intersected by significant variants. CMS value indicates the number of coding genes intersected by significant SNPs with this method.
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